Evidence map›Paper›PMID 26337729›Full record

ArticleHarm reduction journal2015

A qualitative analysis of transitions to heroin injection in Kenya: implications for HIV prevention and harm reduction.

Andy Guise, Margarita Dimova, James Ndimbii, Phil Clark, Tim Rhodes

Open access · goldAbstract read
In one paragraph

Article in Harm reduction journal, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 3 pooled it
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 3 syntheses or guidelines pooled it, 32 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. The Opioid Epidemic in Africa And Its Impact.Current addiction reports · 2018
    Article
  16. Article
  17. Article
  18. Article
  19. Preventing Injection Drug use Initiation: State of the Evidence and Opportunities for the Future.Journal of urban health : bulletin of the New York Academy of Medicine · 2018
    Article
  20. An ethnographic exploration of drug markets in Kisumu, Kenya.The International journal on drug policy · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Andy GuiseCentre for Research on Drugs and Health Behaviour, London School of Hygiene and Tropical Medicine, 15-17 Tavistock Place, London, WC1H 9SH, UK. andy.guise@lshtm.ac.uk.
Margarita DimovaSchool of Oriental and African Studies, Thornhaugh Street, London, WC1H 0XG, UK. md56@soas.ac.uk.
James NdimbiiKenyan AIDS NGOs Consortium, Jabavu Lane, P.O. Box 69866-00400, Nairobi, Kenya. jndimbii@kanco.org.
Phil ClarkSchool of Oriental and African Studies, Thornhaugh Street, London, WC1H 0XG, UK. pc44@soas.ac.uk.
Tim RhodesCentre for Research on Drugs and Health Behaviour, London School of Hygiene and Tropical Medicine, 15-17 Tavistock Place, London, WC1H 9SH, UK. tim.rhodes@lshtm.ac.uk.
London School of Hygiene & Tropical Medicine · GBSOAS University of London · GBKenya AIDS NGOs Consortium · KE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHeroin injection is emerging as a significant dimension of the HIV epidemic in Kenya. Preventing transitions to injecting drug use from less harmful forms of use, such as smoking, is a potentially important focus for HIV prevention. There is, however, little evidence to support comprehensive programming in this area, linked to a shortage of analysis of the social and structural context for transitions, particularly in low-income settings. We explore accounts of transitions from smoking to injecting in Kenya to understand the role of individual, social and structural processes.

methodsWe combine data from two separate studies conducted in Kenya: an in-depth qualitative study of HIV care access for people who inject drugs (study 1) and an ethnographic study of the political economy of the heroin trade in Kenya (study 2). In-depth interviews with PWID and community observation from study 1 are triangulated with accounts from stakeholders involved in the heroin trade and documentary data from study 2.

resultsPeople who inject drugs link transitions to injecting from smoking to a range of social and behavioural factors, as well as particular aspects of the local drug supply and economy. We present these results in the form of two narratives that account for factors shaping transitions. A dominant narrative of 'managing markets and maintaining a high' results from a process of trying to manage poverty and a shifting heroin supply, in the context of deepening addiction to heroin. A secondary narrative focuses on people's curiosity for the 'feeling' of injecting, and the potential pleasure from it, with less emphasis on structural circumstances.

conclusionsThe narratives we describe represent pathways through which structural and social factors interact with individual experiences of addiction to increase the risk of transitions to injecting. In response, HIV and harm reduction programmes need combinations of different strategies to respond to varied experiences of transitions. These strategies should include, alongside behaviour-oriented interventions, structural interventions to address economic vulnerability and the policing of the drug supply.

Indexed as

Harm ReductionQualitative ResearchAdultComorbidityDrug UsersFemaleHeroinHeroin DependenceHIV InfectionsHumansInterviews as TopicKenyaMaleMiddle AgedSubstance Abuse, IntravenousYoung AdultHeroin

Identifiers

PMID26337729
PMCPMC4558953
OpenAlexW1790297625

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.